
Asthma Drugs Global Market Report 2025
Description
Asthma Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on asthma drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for asthma drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The asthma drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type Of Asthma: Allergic; Non-Allergic
2) By Asthma Trigger Type: Adult-Onset Asthma; Child-Onset Asthma; Cough-Induced Asthma; Exercise-Induced Asthma; Occupational Asthma; Nocturnal Asthma; Steroid-Resistant Asthma
3) By Therapy: Preventive; Curative
4) By Drug Class: Bronchodilators; Monoclonal Antibodies; Anti-Inflammatory Drugs; Combination Drugs
5) By End-User: Asthma Patients; COPD Patients
Subsegments:
1) By Allergic: Inhaled Corticosteroids (ICS); Leukotriene Receptor Antagonists (LTRAs); Monoclonal Antibodies
2) By Non-Allergic: Short-Acting Beta Agonists (SABAs); Long-Acting Beta Agonists (LABAs); Oral Corticosteroids
Companies Mentioned: Pfizer Inc.; Roche Holding AG; Merck & Co. Inc.; Bayer AG; Sanofi S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on asthma drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for asthma drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The asthma drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type Of Asthma: Allergic; Non-Allergic
2) By Asthma Trigger Type: Adult-Onset Asthma; Child-Onset Asthma; Cough-Induced Asthma; Exercise-Induced Asthma; Occupational Asthma; Nocturnal Asthma; Steroid-Resistant Asthma
3) By Therapy: Preventive; Curative
4) By Drug Class: Bronchodilators; Monoclonal Antibodies; Anti-Inflammatory Drugs; Combination Drugs
5) By End-User: Asthma Patients; COPD Patients
Subsegments:
1) By Allergic: Inhaled Corticosteroids (ICS); Leukotriene Receptor Antagonists (LTRAs); Monoclonal Antibodies
2) By Non-Allergic: Short-Acting Beta Agonists (SABAs); Long-Acting Beta Agonists (LABAs); Oral Corticosteroids
Companies Mentioned: Pfizer Inc.; Roche Holding AG; Merck & Co. Inc.; Bayer AG; Sanofi S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. Asthma Drugs Market Characteristics
- 3. Asthma Drugs Market Trends And Strategies
- 4. Asthma Drugs Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
- 5. Global Asthma Drugs Growth Analysis And Strategic Analysis Framework
- 5.1. Global Asthma Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Asthma Drugs Market Growth Rate Analysis
- 5.4. Global Asthma Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Asthma Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Asthma Drugs Total Addressable Market (TAM)
- 6. Asthma Drugs Market Segmentation
- 6.1. Global Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Allergic
- Non-Allergic
- 6.2. Global Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Adult-Onset Asthma
- Child-Onset Asthma
- Cough-Induced Asthma
- Exercise-Induced Asthma
- Occupational Asthma
- Nocturnal Asthma
- Steroid-Resistant Asthma
- 6.3. Global Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Preventive
- Curative
- 6.4. Global Asthma Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bronchodilators
- Monoclonal Antibodies
- Anti-Inflammatory Drugs
- Combination Drugs
- 6.5. Global Asthma Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Asthma Patients
- COPD Patients
- 6.6. Global Asthma Drugs Market, Sub-Segmentation Of Allergic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Inhaled Corticosteroids (ICS)
- Leukotriene Receptor Antagonists (LTRAs)
- Monoclonal Antibodies
- 6.7. Global Asthma Drugs Market, Sub-Segmentation Of Non-Allergic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Short-Acting Beta Agonists (SABAs)
- Long-Acting Beta Agonists (LABAs)
- Oral Corticosteroids
- 7. Asthma Drugs Market Regional And Country Analysis
- 7.1. Global Asthma Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Asthma Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Asthma Drugs Market
- 8.1. Asia-Pacific Asthma Drugs Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Asthma Drugs Market
- 9.1. China Asthma Drugs Market Overview
- 9.2. China Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Asthma Drugs Market
- 10.1. India Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Asthma Drugs Market
- 11.1. Japan Asthma Drugs Market Overview
- 11.2. Japan Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Asthma Drugs Market
- 12.1. Australia Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Asthma Drugs Market
- 13.1. Indonesia Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Asthma Drugs Market
- 14.1. South Korea Asthma Drugs Market Overview
- 14.2. South Korea Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Asthma Drugs Market
- 15.1. Western Europe Asthma Drugs Market Overview
- 15.2. Western Europe Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Asthma Drugs Market
- 16.1. UK Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Asthma Drugs Market
- 17.1. Germany Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Asthma Drugs Market
- 18.1. France Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Asthma Drugs Market
- 19.1. Italy Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Asthma Drugs Market
- 20.1. Spain Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Asthma Drugs Market
- 21.1. Eastern Europe Asthma Drugs Market Overview
- 21.2. Eastern Europe Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Asthma Drugs Market
- 22.1. Russia Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Asthma Drugs Market
- 23.1. North America Asthma Drugs Market Overview
- 23.2. North America Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Asthma Drugs Market
- 24.1. USA Asthma Drugs Market Overview
- 24.2. USA Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Asthma Drugs Market
- 25.1. Canada Asthma Drugs Market Overview
- 25.2. Canada Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Asthma Drugs Market
- 26.1. South America Asthma Drugs Market Overview
- 26.2. South America Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Asthma Drugs Market
- 27.1. Brazil Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Asthma Drugs Market
- 28.1. Middle East Asthma Drugs Market Overview
- 28.2. Middle East Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Asthma Drugs Market
- 29.1. Africa Asthma Drugs Market Overview
- 29.2. Africa Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Asthma Drugs Market Competitive Landscape And Company Profiles
- 30.1. Asthma Drugs Market Competitive Landscape
- 30.2. Asthma Drugs Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 31. Asthma Drugs Market Other Major And Innovative Companies
- 31.1. AstraZeneca PLC.
- 31.2. GlaxoSmithKline PLC.
- 31.3. Boehringer Ingelheim International GmbH
- 31.4. Teva Pharmaceutical Industries Ltd.
- 31.5. Novartis International AG
- 31.6. Mylan N.V.
- 31.7. Cipla Limited
- 31.8. Chiesi Farmaceutici S.p.A.
- 31.9. Sun Pharmaceutical Industries Limited
- 31.10. Hikma Pharmaceuticals
- 31.11. Mundipharma International Limited
- 31.12. Lupin Limited
- 31.13. Glenmark Pharmaceuticals Limited
- 31.14. Hetero Drugs Limited
- 31.15. Alembic Pharmaceuticals Limited
- 32. Global Asthma Drugs Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Asthma Drugs Market
- 34. Recent Developments In The Asthma Drugs Market
- 35. Asthma Drugs Market High Potential Countries, Segments and Strategies
- 35.1 Asthma Drugs Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Asthma Drugs Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Asthma Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.